OxMET vs BioCog

OxMET was developed by the Translational Neuropsychology Research Group at the University of Oxford. The OxMET cognitive screen has been standardised, normed and validated (Webb et al 2021, Neuropsychological Rehabilitation). OxMET is suitable for use with adults, and in chronic (greater 6-month post-stoke) and subacute (greater 3 months post-stroke). The tool is not for self-assessment. Instead, OxMET provides health professionals with a brief, ecologically valid, assessment of executive dysfunction using a naturalistic shopping scenario. The test is automatically scored and evaluated against age adjusted norms (three age groups; under 64, between 64 and 72, and over 72). Upon completion, a visual snapshot report is automatically generated and can be stored locally on the device. The information contained in the report is not in itself a clinical diagnosis. The report should be used to inform a clinical diagnosis that takes into account all relevant clinical factors.

The BioFINDER group's digital test suite has been optimised to effectively isolate problems with cognitive health, testing several domains relevant to the onset of cognitive impairment and potential Alzheimer's disease. It has been developed and compiled by experienced neurologists and neuropsychiatrists and includes immediate and delayed memory recall, symbol digit test, trail making, face-occupation and orientation. A study-related active ID is required to perform the tests. The user will be guided through the tests with text and voice-over, for which the following languages are currently supported: Swedish, English, Dutch, Italian, Spanish, Catalan and Finnish.